Financial leverage has surged significantly, with total debt rising to $686.8M in 2025Q2, creating a precarious capital structure that appears disconnected from the firm's operational capacity.
| Total Current Assets | 1.24B | 366.64M | 125.49M | 288.65M | 893.43M | 59.01M | 20.5M |
| Cash & Short-Term Investments | 1.14B | 275.32M | 50.53M | 91.25M | 265.74M | 35.73M | 10.68M |
| Cash Only | 363.44M | 32.43M | 48.16M | 87.81M | 233.85M | 35.33M | 10.64M |
| Short-Term Investments | 776.7M | 242.89M | 2.36M | 3.43M | 31.89M | 400.18K | 34.27K |
| Accounts Receivable | 507.69K | 51.4M | 1.74M | 23.73M | 33.08M | 1.17M | 0 |
| Days Sales Outstanding | 206.38 | 462.17 | 8.1 | 8.81 | 306.11 | 200.07 | - |
| Inventory | 35.85M | 29.87M | 12.87M | 102.2M | 213.87M | 7.24M | 0 |
| Days Inventory Outstanding | 398.02 | 375.99 | 25.85 | 49.54 | 1.79K | 2.08K | - |
| Other Current Assets | 52.59M | 3.24M | 33.6M | -3.28M | 380.74M | 6.14M | 9.83M |
| Total Non-Current Assets | 239.98M | 249.29M | 224.81M | 78.59M | 16.4M | 2.48M | 1.37M |
| Property, Plant & Equipment | 191.73M | 202.55M | 177.08M | 29.87M | 16.4M | 1.84M | 557.01K |
| Fixed Asset Turnover | 0.12x | 0.20x | 0.44x | 32.91x | 2.40x | 1.16x | - |
| Goodwill | 0 | 0 | 0 | -48.67B | 0 | 0 | 0 |
| Intangible Assets | 46.25M | 46.75M | 47.73M | 48.72B | 0 | 99.3K | 265.58K |
| Long-Term Investments | 4M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 550K | 550K |
| Total Assets | 1.48B | 615.93M | 350.3M | 367.24M | 909.83M | 61.49M | 21.88M |
| Asset Turnover | 0.02x | 0.07x | 0.22x | 2.68x | 0.04x | 0.03x | - |
| Asset Growth % | 697.45% | 75.83% | -4.61% | -59.64% | 1379.56% | 181.11% | - |
| Total Current Liabilities | 682.94M | 209.42M | 242.57M | 183.64M | 932.37M | 109.74M | 32.79M |
| Accounts Payable | 23.2M | 18.1M | 16.88M | 15.29M | 2.84M | 5.62M | 509.53K |
| Days Payables Outstanding | 274.2 | 227.88 | 33.88 | 7.41 | 23.79 | 1.61K | - |
| Short-Term Debt | 510.07M | 23.35M | 23.41M | 280K | 0 | 5M | 6.99M |
| Deferred Revenue (Current) | 278.03M | 98.9M | 0 | 124.47M | 917.39M | 65.4M | 0 |
| Other Current Liabilities | 53.03M | 20.47M | 191.79M | 30.86M | 325.95K | 33.25M | 20.45M |
| Current Ratio | 1.81x | 1.75x | 0.52x | 1.57x | 0.96x | 0.54x | 0.63x |
| Quick Ratio | 1.76x | 1.61x | 0.46x | 1.02x | 0.73x | 0.47x | 0.63x |
| Cash Conversion Cycle | 330.2 | 610.28 | 0.07 | 50.94 | 2.08K | 665.93 | - |
| Total Non-Current Liabilities | 175.7M | 173.6M | 123.99M | 19.19M | 2.12M | 276.65K | 112.97K |
| Long-Term Debt | 173.48M | 170.68M | 120.26M | 16.67M | 0 | 0 | 0 |
| Capital Lease Obligations | 11.3M | 2.92M | 3.73M | 2.51M | 2.12M | 276.65K | 112.97K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 858.65M | 383.03M | 366.56M | 202.83M | 934.49M | 110.01M | 32.91M |
| Total Debt | 686.79M | 198.87M | 150.88M | 23.67M | 7.35M | 5.74M | 7.23M |
| Net Debt | 323.35M | 166.43M | 102.72M | -64.14M | -226.51M | -29.59M | -3.41M |
| Debt / Equity | 1.11x | 0.85x | - | 0.14x | - | - | - |
| Debt / EBITDA | -10.42x | - | - | 0.96x | - | - | - |
| Net Debt / EBITDA | -4.91x | - | - | -2.61x | - | - | - |
| Interest Coverage | -5.56x | -14.25x | -283.45x | - | -350.72x | -9852.14x | - |
| Total Equity | 619.08M | 232.91M | -16.26M | 164.41M | -24.66M | -48.52M | -11.03M |
| Equity Growth % | 6171.51% | 1532.28% | -109.89% | 766.68% | 49.17% | -339.85% | - |
| Book Value per Share | 37.41 | 3.44 | -0.28 | 3.06 | -0.47 | -0.93 | -0.28 |
| Total Shareholders' Equity | 621.69M | 230.79M | -14.73M | 164.41M | -24.66M | -48.52M | -11.03M |
| Common Stock | 320.37K | 213.74K | 87K | 72.32K | 66.97K | 51.13K | 51.13K |
| Retained Earnings | -572.27M | -565.22M | -452.03M | -199.21M | -223.68M | -48.74M | -11.03M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 13.45M | 15.29M | 2.25M | 8.75M | -2.47M | 0 | -51.13K |
| Minority Interest | -2.6M | 2.12M | -1.53M | 0 | 0 | 0 | 0 |
Existential liquidity and insolvency
As reported in recent financial filings, Nano Labs' equity position swung from a deficit of $36.3M in 2024Q2 to a positive $621.7M by 2025Q2, a shift that appears driven by external financing rather than organic value creation from the company's core semiconductor operations.
The rapid expansion of the balance sheet suggests a reliance on capital markets to offset persistent operational losses. Investors should monitor whether this capital injection provides a genuine runway for strategic pivots or merely delays an inevitable restructuring of the firm's capital structure.
Based on the latest quarterly data, Nano Labs' total debt surged from $198.9M in 2024Q4 to $686.8M in 2025Q2, indicating a significant increase in financial leverage that appears disconnected from the company's ability to generate sufficient cash flow to service these obligations.
This sharp rise in debt levels warrants further investigation into the terms of these instruments and whether they contain restrictive covenants that could further constrain management's flexibility. The reliance on debt in a period of contracting revenue suggests a high-risk strategy that may exacerbate the company's existing liquidity challenges.
According to financial statements, the current ratio improved to 1.81 in 2025Q2, yet this metric masks the underlying cash burn, as the company's liquidity remains heavily dependent on the successful deployment of recent capital raises rather than sustainable operating cash inflows.
While the current ratio appears improved, the company's history of negative net margins suggests that this liquidity buffer may be consumed rapidly. The lack of consistent cash generation implies that the firm remains vulnerable to shocks in the crypto-mining hardware market, which could quickly deplete available cash reserves.
As evidenced by the accumulated deficit of $572.3M reported in 2025Q2, Nano Labs has consistently eroded shareholder value, with retained earnings reflecting a multi-year trend of significant losses that have necessitated repeated capital infusions to maintain the company's ongoing operations.
The persistent negative retained earnings highlight the difficulty the company faces in achieving profitability within its current business model. Shareholders should be wary of the potential for further dilution, as the company may need to issue additional equity to cover its ongoing operational deficits and debt service requirements.
Quick answers to the most common questions about buying NA stock.
As of 2024, Nano Labs Ltd (NA) had total assets of $615.9M including $366.6M in current assets.
Nano Labs Ltd (NA) carries total debt of $198.9M, offset by $275.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Nano Labs Ltd (NA) has total shareholders' equity (book value) of $230.8M ($3.44 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Nano Labs Ltd (NA) reported a current ratio of 1.75x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.